Support Alert

Drug Safety Update: Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years

The MHRA has issued a drug safety update: chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years. Following a review of the available toxicological data and a calculation of daily exposure to boron from a typical dosing regimen, the MHRA has concluded that the balance between the benefits and risks of chloramphenicol eye drops containing borax or boric acid remains positive for children aged 0 to 2 years. Chloramphenicol eye drops can be safely administered to children aged 0 to 2 years where antibiotic eye drop treatment is indicated.

Further information, including advice for healthcare professionals and advice to provide parents and carers can be found on the MHRA website.

Loading...

Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.

RENEW YOUR MEMBERSHIP TODAY